20
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Dissolution Characteristics of Ibuprofen: Phospholipidcoprecipitates

, &
Pages 155-163 | Published online: 02 Jul 2009
 

Abstract

Ibuprofen powders were blended with phospholipids to prepare physical mixtures or made into solid dispersions by the solvent method and their comparative dissolution profiles were studied. Ibuprofen exhibited significantly improved dissolution rates in phospholipid coprecipitates compared to either physical mixtures or the pure ibuprofen. the coprecipitates of phospholipid-ibuprofen were made at 1:10, 1:20, 1:30 and 1:40 ratios and dissolution profiles were monitored up to 90 minutes. Marginal increase in dissolution rates were observed by increasing the phosopholipid-ibuprofen ratio from 1:40 to 1:20 and further increase to 1:10 ratio did not produce any difference. the coprecipitates of phosopholipid-ibuprofen at a 1:20 ratio showed more than 2 fold increase in the total amount dissolved in water after 90 minutes compared to ibuprofen alone. No significant difference was observed among the three phospholipids in terms of enhancing dissolution rate of ibuprofen in water. When studies were conducted with 1:20 phospholipid—ibuprofen at pH 2.2 medium, the total amount dissolved in water after 90 minutes varied significantly among the phospholipids studied. DSPC showed best results followed by DPPC and DMPC respectively.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.